Retinoid-based compositions and method for preventing adhesion f

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424422, 424443, 424484, 424489, 514559, A61K 9127

Patent

active

055342612

ABSTRACT:
Compositions and methods for prevention of adhesion formation, whereby an effective amount of at least one retinoid, e.g., all trans retinoic acid, is administered for a period of time sufficient to permit tissue repair. The retinoid is preferably administered in conjunction with a delivery vehicle (e.g., microcapsules, microspheres, biodegradable polymer films, lipid-based delivery systems such as liposomes and lipid foams, viscous instillates and absorbable mechanical barriers) useful for maintaining local concentrations of the compound at the injury site at an effective level.

REFERENCES:
patent: 4171318 (1979-10-01), Chan et al.
patent: 4200647 (1980-04-01), Bollag et al.
patent: 4231944 (1980-11-01), Chan et al.
patent: 4326055 (1982-04-01), Loeliger
patent: 4395575 (1983-07-01), Chan et al.
patent: 4396553 (1983-08-01), Klaus
patent: 4544770 (1985-10-01), Broger
patent: 4556518 (1985-12-01), Lucci
patent: 4565863 (1986-01-01), Bollag et al.
patent: 4863969 (1989-09-01), Bollag
patent: 4870219 (1989-09-01), Klaus et al.
patent: 4883613 (1989-11-01), Aig et al.
patent: 4894480 (1990-01-01), Aig et al.
patent: 4900478 (1990-02-01), Gross
patent: 4935560 (1990-06-01), Klaus et al.
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4990703 (1991-02-01), Klaus et al.
patent: 5001276 (1991-03-01), Klaus et al.
patent: 5030764 (1991-07-01), Klaus et al.
patent: 5030765 (1991-07-01), Klaus et al.
patent: 5055622 (1991-10-01), Klaus et al.
patent: 5075333 (1991-12-01), Bryce et al.
patent: 5158773 (1992-10-01), Gross
patent: 5242909 (1995-09-01), Teelmann
patent: 5252604 (1993-10-01), Nagy et al.
patent: 5360789 (1994-11-01), Nakao
Weiyong, CA 122, 96387 1994.
Varani J. Invest. Dermatol. 93 #4, p. 449 (1989.
Abe et al. (1990), "The Effect of Intraperitoneal Administration of Sodium Tolmetin-Hyaluronic Acid on the Postsurgical Cell Infiltration In Vivo," J. Surg. Res., vol. 49, pp. 322-327.
Batova et al. (1992), "Retinoic Acid Induces Secretion of Latent Transforming Growth Factor .beta..sub.1 and .beta..sub.2 in Normal and Human Papillomavirus Type 16-immortalized Human Keratinocytes," Cell Growth & Differentiation, vol. 3, pp. 763-772.
Boehm et al. (1994), "Synthesis of High Specific Activity [.sup.3 H]-9-cis-Retinoic Acid and Its Application for Identifying Retinoids with Unusual Binding Properties," J. Med. Chem., vol. 37, pp. 408-414.
Chatelut et al. (1993), "A Slow-Release Methotrexate Formulation for Intrathecal Chemotherapy," Cancer Chemother. Pharmacol., vol. 32, pp. 179-182.
Conese et al. (1991), "Inhibitory Effect of Retinoids on the Generation of Procoagulant Activity by Blood Nononuclear Phacocytes," Thrombosis and Haemostasis, vol. 66, pp. 662-665.
Diamond et al. (1991), "Synergistic Effects of INTERCED (TC7) and Heparin in Reducing Adhesion Formation in the Rabbit Uterine Horn Model," Fertility and Sterility, vol. 55, pp. 389-394.
Diamond et al. (1991), "Adhesion Reformation: Reduction by the Use of Interceed (TCU) Plus Heparin," J. Gynecologic Surgery, vol. 7, pp. 1-6.
diZerega and Rodgers (1992), "Prevention of Postoperative Adhesions", in The Peritoneum, diZerega and Rodgers, eds., Springer-Verlag, New York, pp. 307-369.
Doepner et al. (1992), "Effects of Novel Retinoids on Growth and Differentiation of a Rhabdomyosarcoma Cell Line," Arzneim.-Forsch/Drug. Res., vol. 42, pp. 1036-1040.
Elkins, Thomas (1990), "Can a Pro-Coagulant Substance Prevent Adhesions,?" in Treatment of Post-SurgicalAdhesions, diZerega et al., eds., Wiley-Liss, New York, pp. 103-112.
Fumarulo et al. (1991), "Retinoids Inhibit the Respiratory Burst and Degranulation of Stimulated Human Polymorphonuclear Leukocytes," Agents and Actions, vol. 34, pp. 339-344.
Giordano et al. (1993), "Sustained Delivery of Retinoic Acid from Microspheres of Biodegradable Polymer in PVR," Investigative Ophthalmology & Visual Science, vol. 34, pp. 2743-2751.
Glasser et al. (1994), "Functional Characteristics of In Vivo Induced Neutrophils After Differentiation Therapy of Acute Promyelocuytic Leukemia with All-Trans-Retinoic Acid," Cancer, vol. 73, pp. 1206-1212.
Goettsch et al. (1992), "Adjuvant Activity of All-Trans-Retinoic Acid in C57B1/6 Mice," J. Immunopharmac., vol. 14, pp. 143-150.
Hamasaki et al. (1994), "Specific Induction of LTC4 Synthase by Retinoic Acid in Rat Basophilic Leukemia-1 Cells," Int. Arch. Allergy Immunol., vol. 103, pp. 260-265.
Hershlag et al. (1991), "The Effect of Interleukin-1 on Adhesion Formation in the Rat," Am. J. Obstet. Gynecol., vol. 165, pp. 771-774.
Hockel et al. (1987), "Prevention of Peritoneal Adhesions in the Rat with Sustained Intraperitoneal Dexamethasone Delivered by a Novel Therapeutic System," Annales Chirurgiae et Gynaecologiae, vol. 76, pp. 306-313.
Horie et al. (1992), "Retinoic Acid Stimulates Expression of Thrombomoduli, a Cell Surface Anticoagulant Glycoprotein, on Human Endothelial Cells," Biochem. J., vol. 281, pp. 149-154.
Immonen et al. (1993), "Retinoids Increase Urokinase-Type Plasminogen Activator Production by Human Retinal Pigment Epithelial Cells in Culture," Invest. Ophthalmol., vol. 34, pp. 2062-2067.
Ishii et al. (1992), "Retinoic Acid Counteracts Both the Downregulation of Thrombomodulin and the Induction of Tissue Factor in Cultured Human Endothelial Cells Exposed to Tumor Necrosis Factor," Blood, vol. 80, pp. 2556-2562.
Johnson and Johnson (1989), "Prevention of Postsurgical Adhesions by INTERCEED (TC7), an Absorbable Adhesion Barrier: A Prospective Randomized Multicenter Clinical Study," Fertility and Sterility, vol. 51, pp. 933-938.
Kim et al. (1992), "Effect of Topical Retinoic Acids on the Levels of Collagen mRNA During the Repair of UVB-Induced Dermal Damage in the Hairless Mouse and the Possible Role of TGF-.beta. as a Mediator," J. Investigative Dermatology, vol. 98, pp. 359-363.
Kim et al. (1993), "Extended-Release Formulation of Morphine for Subcutaneous Administration," Cancer Chemother. Pharmacol., vol. 33, pp. 187-190.
Kistler et al. (1990), "Teratogenicity of Arotinoids (Retinoids) In Vivo and In Vitro," Arch. Toxicol., vol. 64, pp. 616-622.
Lewis, Danny (1990), "Controlled Release of Bioactive Agents from Lactide-Glycolide Polymers," in Biodegradable Polymers as Drug Delivery Systems, Jason & Langer, eds., pp. 1-41.
McBride et al. (1989), "Effect of Interleukin 1, Inflammation, and Surgery on the Incidence of Adhesion Formulation and Death After Abdominal Irradiation in Mice," Cancer Research, vol. 49, pp. 169-173.
Medh et al. (1992), "Stimulation of Tissue Plasminogen Activator Production by Retinoic Acid: Synergistic Effect on Protein Kinase C-Mediated Activation," Blood, vol. 80, pp. 981-987.
Mehta et al. (1994), "Inhibition by All-Trans-Retinoic Acid of Tumor Necrosis Factor and Nitric Oxide Production by Peritoneal Macrophages," J. Leukocyte Biology, vol. 55, pp. 336-342.
Nair et al. (1991), "BMY 30047: A Novel Topically Active Retinoid with Low Local and Systemic Toxicity," J. Pharmacology & Experimental Therapeutics, vol. 256, pp. 365-370.
Nishimura et al. (1984), "Ibuprofen in the Prevention of Experimentally Induced Postoperative Adhesions," Am. J. Med., vol. 77, pp. 102-106.
Oikawa et al. (1993), "Three Novel Synthetic Retinoids, Re 80, Am 580 and Am 80, All Exhibit Anti-Angiogenic Activity In Vivo," European J. Pharmacology, vol. 249, pp. 113-116.
Repa et al. (1993), "All-trans-retinol is a Ligand for the Retinoic Acid Receptors," Proc. Natl. Acad. Sci. USA, vol. 90, pp. 7293-7297.
Rodgers et al. (1988), "Effects of Tolmetin Sodium Dihydrate on Normal and Postsurgical Peritoneal Cell Function," Int. J. Immunopharmac., vol. 10, pp. 111-120.
Rodgers et al. (1990), "Intraperitoneal Tolmetin Prevents Postsurgical Adhesion Formation in Rabbits," Int. J. Fertil., vol. 35, pp. 40-45.
Rodgers, K. (1990), "Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in the Treatment of Postsurgical Adhesion," in Treatment of Post Surgical Adhesions, Wiley-Liss, Inc., pp. 119-129.
Schuster et al. (1993), "Retinoic Acid Potentiates Phorbol Ester-Mediated Induction of Urokinase and Plasminogen Activatory Inhibitor Type 2 in Human Myeloid Leukemic

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Retinoid-based compositions and method for preventing adhesion f does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retinoid-based compositions and method for preventing adhesion f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoid-based compositions and method for preventing adhesion f will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1865532

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.